
X
Roche stops dosing in trial of Huntington’s disease hopeful tominersen
https://pharmaphorum.com/news/roche-stops-dosing-in-huntingtons-disease-trial/
BioSensics’ HDWear provides real-time motor function scores in Huntington’s patients.
First treatment approved for Huntington’s Disease in almost a decade.
SD-809 will be vital for Teva if approved.
FDA rejected drug earlier this year.